These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2364092)

  • 21. Distortion of the active site of chymotrypsin complexed with a serpin.
    Plotnick MI; Mayne L; Schechter NM; Rubin H
    Biochemistry; 1996 Jun; 35(23):7586-90. PubMed ID: 8652540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structures and properties of molecular torsion balances to decipher the nature of substituent effects on the aromatic edge-to-face interaction.
    Gardarsson H; Schweizer WB; Trapp N; Diederich F
    Chemistry; 2014 Apr; 20(16):4608-16. PubMed ID: 24652763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactions of alpha-chymotrypsin with 4-(trifluoromethyl)-alpha-bromoacetanilide.
    Ando ME; Gerig JT
    Biochemistry; 1982 May; 21(10):2299-304. PubMed ID: 7093189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, structure-activity relationships studies of benzoxazinone derivatives as α-chymotrypsin inhibitors.
    Marasini BP; Rahim F; Perveen S; Karim A; Mohammed Khan K; Atta-Ur-Rahman ; Choudhary MI
    Bioorg Chem; 2017 Feb; 70():210-221. PubMed ID: 28087168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of chymotrypsin by fluorinated alpha-keto acid derivatives.
    Parisi MF; Abeles RH
    Biochemistry; 1992 Oct; 31(39):9429-35. PubMed ID: 1327115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An 1H NMR determination of the three-dimensional structures of mirror-image forms of a Leu-5 variant of the trypsin inhibitor from Ecballium elaterium (EETI-II).
    Nielsen KJ; Alewood D; Andrews J; Kent SB; Craik DJ
    Protein Sci; 1994 Feb; 3(2):291-302. PubMed ID: 8003965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NMR chemical shift mapping of the binding site of a protein proteinase inhibitor: changes in the (1)H, (13)C and (15)N NMR chemical shifts of turkey ovomucoid third domain upon binding to bovine chymotrypsin A(alpha).
    Song J; Markley JL
    J Mol Recognit; 2001; 14(3):166-71. PubMed ID: 11391787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A proton-magnetic-resonance study of N-trifluoroacetyl-L-alanyl-L-phenylalaninal binding to alpha-chymotrypsin.
    Wyeth P; Sharma RP; Akhtar M
    Eur J Biochem; 1980 Apr; 105(3):581-5. PubMed ID: 6245886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of chymotrypsin by 5-benzyl-6-chloro-2-pyrone: 13C NMR and X-ray diffraction analyses of the inactivator-enzyme complex.
    Ringe D; Seaton BA; Gelb MH; Abeles RH
    Biochemistry; 1985 Jan; 24(1):64-8. PubMed ID: 3994973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenothiazine-N-carbonyl chloride, a specific inactivator of chymotrypsin.
    Erlanger BF; Vratsanos SM; Wassermann NH; Cooper AG
    Biochem J; 1970 Jul; 118(3):421-5. PubMed ID: 5472167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of serine protease inhibitors with conformation restricted by amino acid side-chain-side-chain CH/pie interaction.
    Shimohigashi Y; Nose T; Yamauchi Y; Maeda I
    Biopolymers; 1999; 51(1):9-17. PubMed ID: 10380349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chymotrypsin inhibition induced by side chain-side chain intramolecular CH/pi interaction in D-Thr-L-Phe benzylamide.
    Maeda I; Shimohigashi Y; Ikesue K; Nose T; Ide Y; Kawano K; Ohno M
    J Biochem; 1996 May; 119(5):870-7. PubMed ID: 8797086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for multiple forms of p-trifluoromethylbenzenesulfonyl-alpha-chymotrypsin.
    Ando ME; Gerig JT; Luk KF; Roe DC
    Can J Biochem; 1980 May; 58(5):427-33. PubMed ID: 7407679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational specificity of chymotrypsin toward proline-containing substrates.
    Fischer G; Bang H; Berger E; Schellenberger A
    Biochim Biophys Acta; 1984 Nov; 791(1):87-97. PubMed ID: 6498206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A conformational change in the benzeneboronic acid-alpha-chymotrypsin complex. Evidence for a conformational change in a tetrahedral adduct of alpha-chymotrypsin.
    Hanai K
    J Biochem; 1977 May; 81(5):1273-83. PubMed ID: 197063
    [No Abstract]   [Full Text] [Related]  

  • 36. NMR solution structure of Apis mellifera chymotrypsin/cathepsin G inhibitor-1 (AMCI-1): structural similarity with Ascaris protease inhibitors.
    Cierpicki T; Bania J; Otlewski J
    Protein Sci; 2000 May; 9(5):976-84. PubMed ID: 10850807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Esters and amides of 6-(chloromethyl)-2-oxo-2H-1-benzopyran-3-carboxylic acid as inhibitors of alpha-chymotrypsin: significance of the "aromatic" nature of the novel ester-type coumarin for strong inhibitory activity.
    Pochet L; Doucet C; Schynts M; Thierry N; Boggetto N; Pirotte B; Jiang KY; Masereel B; de Tullio P; Delarge J; Reboud-Ravaux M
    J Med Chem; 1996 Jun; 39(13):2579-85. PubMed ID: 8691456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1H and 13C NMR relaxation studies of molecular dynamics of the thyroid hormones thyroxine, 3,5,3'-triiodothyronine, and 3,5-diiodothyronine.
    Duggan BM; Craik DJ
    J Med Chem; 1996 Sep; 39(20):4007-16. PubMed ID: 8831766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substituted 3-(phenylsulfonyl)-1-phenylimidazolidine-2,4-dione derivatives as novel nonpeptide inhibitors of human heart chymase.
    Niwata S; Fukami H; Sumida M; Ito A; Kakutani S; Saitoh M; Suzuki K; Imoto M; Shibata H; Imajo S; Kiso Y; Tanaka T; Nakazato H; Ishihara T; Takai S; Yamamoto D; Shiota N; Miyazaki M; Okunishi H; Kinoshita A; Urata H; Arakawa K
    J Med Chem; 1997 Jul; 40(14):2156-63. PubMed ID: 9216834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical and biological effects of substitution of the 2-position of ring-expanded ('fat') nucleosides containing the imidazo[4,5-e][1,3]diazepine-4,8-dione ring system: the role of electronic and steric factors on glycosidic bond stability and anti-HCV activity.
    Zhang P; Zhang N; Buckwold VE; Hosmane RS
    Bioorg Med Chem; 2007 Jul; 15(14):4933-45. PubMed ID: 17507230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.